—Neurobiologist Özgün Gökce was recently recruited to the German Center of Neurodegenerative Diseasses (DZNE) on campus of at the University Hospital Bonn. He is also a member of the Medical Faculty at Bonn University. As head of the research group "Systems Neuroscience – Cell Diversity", Gökce has been appointed as a member of ImmunoSensation2 from March 2023.
Women TechEU Start-Up Funding for University of Bonn Spin-Off
—relios.vision GmbH, a University of Bonn start-up that has developed the SmartContrast software, receives funding from the European Innovation Council’s (EIC) Women TechEU program. ImmunoSensation² member Prof. Alexander Effland, together with experts from the fields of medicine and mathematics is involved in the company. Using artificial intelligence, SmartContrast aims to lower the use of contrast agents for magnetic resonance imaging of the brain, thus reducing examination costs and potential risks for patients and the environment.
International Conference: Mathematics meets Life Sciences
—Researchers discuss at a four-day symposium, organized by the Bonn Clusters of Excellence ImmunoSensation² and HCM, and the TRAs "Modelling" and "Life and Health".
—The multimedia report "Beyond the boundaries" introduces some outstanding group leaders at ImmunoSensation². The report highlights the scientific work of three young scientist, focussing on their innovative research approaches as well as showcasing the excellent research environment at the University of Bonn. The project was suported by the Henriette Herz Award of the Alexander von Humboldt Foundation.
—The research group led by Dr. Laura Surace at the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn has received funding from the German Cancer Aid through the Max Eder Junior Research Group Program. The program was established to specifically support the research of up-and-coming young oncologists. This is intended to benefit not only the field of oncology, but also the training of the researchers. Surace joins a group of around 30 young scientists who are being supported throughout Germany.
—Immunologist Tim Rollenske was recently recruited to the Institute of Molecular Medicine and Experimental Immunology at the University Hospital Bonn. As head of the newly formed research group "Mucosal Immunology", he has been appointed as a member of ImmunoSensation² from March 2023. We met Tim Rollenske to talk about his research interests and future perspectives at the Cluster of Excellence, here in Bonn.
—For more than 50 years, it has been suspected that adipocytes permanently remodel the lipids stored in them. ImmunoSensation² member Christoph Thiele and his team at the University of Bonn have now for the first time demonstrated this process in cell culture. The study shows that the cells are able to quickly eliminate harmful fatty acids or alternatively refine them into more usable molecules. The results have now been published in the journal Nature Metabolism.
—Last Thursday, Dr. Inga Hochheiser from the Institute of Structural Biology at the University Hospital Bonn (UKB) received the Bayer Pharmaceuticals PhD Award 2023 for the best molecular biology PhD of the past year. The Bayer Pharmaceuticals Doctoral Award is presented by the Society for Biochemistry and Molecular Biology (GBM).
Beethoven’s genome offers clues to composer’s health and family history
—Ludwig van Beethoven’s genome has been sequenced for the first time by an international team of scientists with the participation of ImmunoSensation² member Prof. Markus Nöthen at the University of Bonn, using five genetically matching locks of the well-known composer’s hair.
